Cardiac Arrhythmia and Device Management in Patients with Cancer

  • Kaveh KarimzadEmail author


In this chapter we have briefly discussed the management of torsade de pointe and cardiac devices, in patients with cancer.


Torsade de pointes Cardiac devices 


  1. 1.
    Calfee RV. Therapeutic radiation and pacemakers. Pacing Clin Electrophysiol. 1982;5(2):160–1.CrossRefPubMedGoogle Scholar
  2. 2.
    Crossley GH, Poole JE, Rozner MA, Asirvatham SJ, Cheng A, Chung MK, Ferguson TB Jr, Gallagher JD, Gold MR, Hoyt RH, Irefin S, Kusumoto FM, Moorman LP, Thompson A. The Heart Rhythm Society (HRS)/American Society of Anesthesiologists (ASA) Expert Consensus Statement on the perioperative management of patients with implantable defibrillators, pacemakers and arrhythmia monitors: facilities and patient management. Heart Rhythm. 2011;8(7):1114–54.CrossRefPubMedGoogle Scholar
  3. 3.
    Hurkmans CW, Knegjens JL, Oei BS, Maas AJ, Uiterwaal GJ, van der Borden AJ, Ploegmakers MM, van Erven L, Dutch Society of Radiotherapy and Oncology (NVRO). Management of radiation oncology patients with a pacemaker or ICD: a new comprehensive practical guideline in The Netherlands. Radiat Oncol. 2012;7:198.CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Kapa S, Fong L, Blackwell CR, Herman MG, Schomberg PJ, Hayes DL. Effects of scatter radiation on ICD and CRT function. Pacing Clin Electrophysiol. 2008;31(6):727–32.CrossRefPubMedGoogle Scholar
  5. 5.
    Hurkmans CW, Scheepers E, Springorum BG, Uiterwaal H. Influence of radiotherapy on the latest generation of implantable cardioverter-defibrillators. Int J Radiat Oncol Biol Phys. 2005;63(1):282–9.CrossRefPubMedGoogle Scholar
  6. 6.
    Kay GN, Plumb VJ, Arciniegas JG, Henthorn RW, Waldo AL. Torsade de pointes: the long-short initiating sequence and other clinical features: observations in 32 patients. J Am Coll Cardiol. 1983;2:806–17.CrossRefPubMedGoogle Scholar
  7. 7.
    Moss AJ, Schwartz PJ, Crampton RS, Tzivoni D, Locati EH, MacCluer J, Hall WJ, Weitkamp L, Vincent GM, Garson A Jr, Robinson JL, Benhorin J, Choi S. The long QT syndrome: prospective longitudinal study of 328 families. Circulation. 1991;84:1136–44.CrossRefPubMedGoogle Scholar
  8. 8.
    Zareba W, Moss AJ, Schwartz PJ, Vincent GM, Robinson JL, Priori SG, Benhorin J, Locati EH, Towbin JA, Keating MT, Lehmann MH, Hall WJ. Influence of genotype on the clinical course of the long-QT syndrome: International Long-QT Syndrome Registry Research Group. N Engl J Med. 1998;339:960–5.CrossRefPubMedGoogle Scholar
  9. 9.
    Lazzara R. Amiodarone and torsade de pointes. Ann Intern Med. 1989;111:549–51.CrossRefPubMedGoogle Scholar
  10. 10.
    Roden DM. Drug-induced prolongation of the QT interval. N Engl J Med. 2004;350:1013–22.CrossRefPubMedGoogle Scholar
  11. 11.
    Díiaz-Castro O, Puchol A, Almendral J, Torrecilla EG, Arenal A, Martínez-Selles M. Predictors of in-hospital ventricular fibrillation or torsades de pointes in patients with acute symptomatic bradycardia. J Electrocardiol. 2004;37(1):55–60.CrossRefGoogle Scholar
  12. 12.
    Grunsfeld A, Fletcher JJ, Nathan BR. Cardiopulmonary complications of brain injury. Curr Neurol Neurosci Rep. 2005;5:488–93.CrossRefPubMedGoogle Scholar
  13. 13.
    Hersch C. Electrocardiographic changes in subarachnoid haemorrhage, meningitis and intracranial space occupying lesions. Br Heart J. 1964;26:785–93.CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Department of CardiologyUniversity of Texas MD Anderson Cancer CenterHoustonUSA

Personalised recommendations